From Bench to Bedside: Anti-MCV as a Marker in Rheumatoid ArthritisFrom Bench to Bedside: Anti-MCV as a Marker in Rheumatoid Arthritis

In this episode, powered by WHX Labs Dubai, formerly Medlab Middle East, in partnership with Sebia, we explore the evolving landscape of autoimmune diagnostics and innovation, with a focus on anti-MCV as a key marker for rheumatoid arthritis.

Our host, Peter Birch, is joined by Dr. Oliver Sendscheid, Autoimmunity Business Area Director at Sebia, and Prof. Dr. med. Eugen Feist, Chief Physician at Rheumatology Clinic and Medical Director at Helios Specialist Clinic Vogelsang-Gommern, Germany, to explore how diagnostics are transforming rheumatoid arthritis care, the challenges of bringing lab innovations to the bedside, and what the future holds for autoimmune disease management.

🎧 Listen on Spotify or Apple Podcasts

▶️ Watch the episode on YouTube